+
Site Tour
TRICLIP™
TRICUSPID
VALVE REPAIR
TRANSCATHETER
EDGE-TO-EDGE REPAIR (TEER)

 

Built upon a proven clip-based platform, TriClip™ Transcatheter Edge-to-Edge Repair (TEER) offers a minimally invasive treatment option for patients with symptomatic, severe Tricuspid Regurgitation (TR) who are at high risk for surgery.

Discover why Experience Matters

WATCH HOW TRICLIP™ TEER TRANSFORMED CRUZ'S LIFE

TriClip

FIND OUT MORE:

DOWNLOAD FLYER

SPECIFICALLY DESIGNED
FOR THE TRICUSPID VALVE1

TriClip™ Transcatheter Edge-to-Edge Repair (TEER) offers unmatched stability, precision, and control2* required for the unique challenges of the tricuspid anatomy to achieve sustained, clinically significant improvements in the lives of patients with Tricuspid Regurgitation (TR).3,4

  • Significant TR reduction3-5
  • Strong safety profile3-5
  • Life changing improvements in health related quality of life3-5
  • Proven in the largest body of Tricuspid TEER evidence to date3-5

* Based on Abbott simulated horizontal tensile testing.

FIND OUT MORE ABOUT:

TRICUSPID REGURGITATION   TREATMENT OPTIONS   CLINICAL DATA

Connext
TV

CONNECT TO THE LATEST
IN STRUCTURAL HEART
THERAPY

Find out more

TV

AV VALVES 2023: Fast Forward 20 Years

AV VALVES Summit 2023 Shaping the Future Part II: Fast Forward 20 Years

AV VALVES 2023: The Genesis of TEER

AV VALVES Summit 2023 Shaping the Future Part I: 20 years – The Genesis of TEER

AV VALVES 2023: TA, TF in TMVR

AV VALVES Summit 2023 Trending Controversies Round 3: TA, TF in TMVR

AV VALVES 2023: Replace, Repair in TR

AV VALVES Summit 2023 Trending Controversies Round 2: Replace, Repair in TR

AV VALVES 2023: Staged, Concomitant

AV VALVES Summit 2023 Trending Controversies Round 1: Staged, Concomitant 

AV VALVES 2023:Decision Making in HF–Tricuspid

AV VALVES Summit 2023 Decision Making in HF:How & when should I treat? Part II Tricuspid

AV VALVES 2023:Decision Making in HF – Mitral

AV VALVES Summit 2023 Decision Making in HF: How & when should I treat? Part I Mitral 

AV VALVES 2023:HF and VHD – Patient Management

AV VALVES Summit 2023 HF and VHD: Changing the Paradigm of Patient Management

AV VALVES 2023: Live Case – T-TEER

AV VALVES Summit 2023 Live Case: Tricuspid TEER

AV VALVES 2023: TR – Big Gaps

AV VALVES Summit 2023 Case Parade Tricuspid: Big Gaps

References
  1. Data on file at Abbott.
  2. Testing performed by and data on file at Abbott.
  3. von Bardeleben RS, Lurz P, Sitges M, et al. Percutaneous edge-to-edge repair for tricuspid regurgitation: 2-year outcomes from the TRILUMINATE trial. Presented at EuroPCR 2021.
  4. Lurz P, Schueler R, Goebel B, et al. Real-world outcomes for tricuspid edge-to-edge repair: initial 30-day results from the TriClip™ bRIGHT Study. Presented at PCR London Valves 2021.
  5. Lurz P, von Bardeleben RS, Weber M, et al. Transcatheter edge-to-edge repair for treatment of tricuspid regurgitation. J Am Coll Cardiol. 2021;77(3):229–239. doi.org/10.101 /j.jacc.2020.11.038.
  6. Benfari G, Antoine C, Mille WL, et al. Excess mortality associated with functional tricuspid regurgitation complicating heart failure with reduced ejection fraction. Circulation. 2019;140(3):196–206. doi.org/10.1161/CIRCULATIONAHA.118.038946.
  7. Asmarats L, Puri R, Latib A, et al. Transcatheter tricuspid valve interventions: landscape, challenges, and future directions. J Am Coll Cardiol. 2018;71(25):2935–2956. doi.org/10.1016/j.jacc.2018.04.031.
  8. Enriquez-Sarano M, Messika-Zeitoun D, Topilsky Y, et al. Tricuspid regurgitation is a public health crisis. Prog Cardiovasc Dis. 2019;62(6):447–451. doi.org/10.1016/j.pcad.2019.10.009.
  9. Wong WK, Chen SW, Chou AH, et al. Late outcomes of valve repair versus replacement in isolated and concomitant tricuspid valve surgery: a nationwide cohort study. J Am Heart Assoc. 2020;9(8):e015637. doi.org/10.1161/JAHA.119.015637.
  10. Moraca RJ, Moon MR, Lawton JS, et al. Outcomes of tricuspid valve repair and replacement: a propensity analysis. Ann Thorac Surg. 2009;87(1):83–8; discussion 88¬–9. doi.org/10.1016/j.athoracsur.2008.10.003.

© Abbott 2023. All rights reserved. 9-EH-5-14379-01 07-2023

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline